Your family, friends and, yes, neighbors are a little concerned: Your house has been on the market for quite some time and theyre beginning to wonder. Will it ever sell?
SEE ALSO: 7 Features Home Buyers Want Most
Youre beginning to wonder, too. So lets back up a bit: Did you and the real estate agent representing your property have a good heart-to-heart about the asking price? Did you look at recent sales and comparable listings in your neighbor (comps, in Realtor-speak)? Or did you balk at the figure the agent calculated for your home and wanted it higher?
An unrealistic asking price is the obvious reason a home will linger on the market. Here are seven more reasons that might be less obvious, but they nonetheless could be keeping your house from attracting bids.
Top 5 Up And Coming Stocks To Watch Right Now: Rex Energy Corporation(REXX)
Rex Energy Corporation operates as an independent oil and gas company in the Appalachian Basin and the Illinois Basin. It focuses on the Marcellus Shale drilling projects, and Utica Shale and Upper Devonian Shale exploration activities in the Appalachian Basin. The company also holds interests in the Lawrence Field ASP Flood project, which is an oil recovery project located in Lawrence County, Illinois. As of December 31, 2011, it operated approximately 2,117 wells, including approximately 517 disposal and injection wells. The company had estimated proved reserves of 366.2 billions of cubic feet equivalent. Rex Energy Corporation was founded in 2007 and is headquartered in State College, Pennsylvania.
- [By Ben Levisohn]
Our peer group is up an average of 46% over the past 4 weeks in response to a 30% rebound in the 12-month strip NYMEX oil price. Some of the largest gainers include Hold and Sell rated stocks that we would not chase such asDenbury Resources (Sell, +138%), Halcon Resources (HK) (Sell, +147%), Jones Energy (JONE) (Hold, +166%), Rex Energy (REXX) (Sell, +60%), Sanchez Energy (SN) (Hold, +93%), Ultra Petroleum (UPL) (Sell, +61%), andWhiting Petroleum (Hold, +103%), which have outperformed the E&P Index (+32%) over the same time period. Balance sheets and/or well level returns remain challenged for these companies despite improved oil prices. While we believe oil markets should re-balance over the next 12 to 15 months, the recent recovery to $40 could reverse during 2Q16 as bloated inventories continue to rise, new volumes from Iran pressure an oversupplied market, and a highly anticipated decline in non-OPEC supply (especially in the U.S.), is not as steep as expected. The risk of an oil price retracement, which would significantly pressure the recent out-performers, outweighs the upside in these stocks, in our view. However, we are raising our target prices on Buy ratedAnadarko Petroleum ($54 from $48), Concho Resources (CXO) ($120 from $109), Matador Resources (MTDR) ($22 from $21),Noble Energy (NBL) ($40 from $34), SM Energy (SM) ($22 from $15), Rice Energy ($14 from $12), Pioneer Natural Resources (PXD) ($155 from $135),Continental Resources ($32 from $28), and Parsley Energy (PE) ($24 from $23). We believe our Buy-rated stocks are better positioned to weather challenging oil markets.
Top 5 Up And Coming Stocks To Watch Right Now: Amgen Inc.(AMGN)
Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
- [By Ben Levisohn]
The technicians love the biotech sector–and the iShares Nasdaq Biotechnology ETF (IBB)–today. Earlier today, we discussed Cornerstone Macro’s Carter Worth, who predicts big upside for the health-care sector generally, and some biotech stocks specifically, Regeneron Pharmaceuticals (REGN) and Amgen (AMGN) among them. Now, the folks at Bespoke Investment Group have published their own now–Biotech Breakout?–about the sector. They write:
- [By Ben Levisohn]
Reports suggest that Gilead Sciences (GILD) and Celgene (CELG) have joined the bidding process forMedivation (MDVN), one that already includes (maybe) Amgen (AMGN), and of course Sanofi (SNY), which is trying to throw out Medivation’s board. Of the three biotech giants, Citigroup’s Robyn Karnauskas and team argue that Amgen is best positioned to win the battle. They explain why:
- [By Ben Levisohn]
After Gilead Sciences (GILD) and Amgen (AMGN) left investors wanting more, it might have been fair to wonder if Celgene (CELG) would meet the same fate when it released earnings this morning. It didn’t. And unlike Gilead and Amgen, whose shares dropped after their earnings release, Celgene is gaining.
Top 5 Restaurant Stocks To Buy For 2016: Humana Inc.(HUM)
Humana Inc. offers various health and supplemental benefit plans in the United States. Its Government segment consists of beneficiaries of government benefit programs; and operates in three lines of businesses, including Medicare, Military, and Medicaid. The Medicare program provides hospital and medical insurance benefits to persons of age 65 and over and some disabled persons under the age of 65. The Military program offers health insurance coverage to the dependents of duty military personnel, and to retired military personnel and their dependents. The Medicaid program is a federal program that is state-operated to facilitate the delivery of health care services primarily to low-income residents. The Commercial segment consists of members enrolled in its medical and specialty products marketed to employer groups and individuals. This segment provides health maintenance organization products that offer prepaid health insurance coverage to its members through a network of independent primary care physicians, specialty physicians, and other health care providers; preferred provider organization products, which are offered primarily to employer groups and individuals; and administrative services only products that are provided to employers who self-insure their employee health plans. It also offers various specialty products, including dental, vision, and other supplemental products, as well as disease management services. As of December 31, 2010, Humana Inc. had approximately 10.2 million members enrolled in medical benefit plans; and approximately 7.1 million members enrolled in specialty products programs. The company markets its products through various channels comprising television, radio, the Internet, telemarketing, and direct mailings. In addition, it has strategic alliances with Wal-Mart Stores, Inc.; State Farm; and United Services Automobile Association to market its products. The company was founded in 1961 and is headquartered in Louisville, Kentucky.
- [By Ben Levisohn]
The Wall Street Journal reported that government regulators are pushing back against Anthem’s (ANTM) purchase of Cigna (CI). California, however, seems to have few issues with the proposed combination of Aetna (AET) andHumana (HUM). Leerink’s Ana Gupte explains:
Top 5 Up And Coming Stocks To Watch Right Now: Nabors Industries Ltd.(NBR)
Nabors Industries Ltd., together with its subsidiaries, provides drilling and rig services. It offers equipment manufacturing, rig instrumentation, optimization software, and directional drilling services; and patented steering systems and rig instrumentation software systems, including ROCKIT directional drilling system that provides data collection services to oil and gas exploration and service companies, and RIGWATCH software, which monitors a rigs real-time performance and daily reporting for drilling operations. The company also manufactures and sells top drives, catwalks, wrenches, draw works, and other drilling related equipment; and offers well-site services, such as engineering, transportation and disposal, construction, maintenance, well logging, directional drilling, data collection, and other support services. As of December 31, 2015, it marketed approximately 430 rigs for land-based drilling operations in the U nited States, Canada, and approximately 20 other countries worldwide; and 42 rigs for offshore drilling operations in the United States and internationally; and 6 jackup units. The company was founded in 1968 and is headquartered in Hamilton, Bermuda.
- [By Monica Gerson]
Nabors Industries Ltd. (NYSE: NBR) is expected to post a quarterly loss at $0.33 per share on revenue of $630.85 million.
Sohu.com Inc (NASDAQ: SOHU) is projected to report a quarterly loss at $0.57 per share on revenue of $406.50 million.
Top 5 Up And Coming Stocks To Watch Right Now: Dean Foods Company(DF)
Dean Foods Company, together with its subsidiaries, operates as a food and beverage company in the United States. It operates in two segments, Fresh Dairy Direct-Morningstar and WhiteWave-Alpro. The Fresh Dairy Direct-Morningstar segment manufactures, markets, and distributes various branded and private label dairy case products, including cream, ice cream mix, and ice cream novelties; creamers and other extended shelf life fluids; yogurt, cottage cheeses, sour creams, and dairy-based dips; fruit juices, fruit-flavored drinks, iced teas, and water; half-and-half and whipping creams; and items for resale, such as butter, cheese, eggs, and milk shakes. This segment sells its dairy case products to retailers, distributors, foodservice outlets, educational institutions, and governmental entities. The WhiteWave-Alpro segment manufactures, develops, markets, and sells various branded dairy and dairy-related products, such as milk and other dairy products; organic dairy products; plant-based beverages, such as soy, almond, and coconut milks; and soy food products, coffee creamers, and creamers and fluid dairy products. It also provides branded soy-based beverages and food products in Europe under the Alpro and Provamel brands. This segment sells its products to various customers, including grocery stores, club stores, natural foods stores, mass merchandisers, convenience stores, drug stores, and foodservice outlets. The company was formerly known as Suiza Foods Corporation and changed its name to Dean Foods Company on December 21, 2001 as a result of merger between the former Dean Foods Company and Suiza Foods Corporation. Dean Foods Company was founded in 1995 and is headquartered in Dallas, Texas.
- [By Monica Gerson]
Analysts are expecting Dean Foods Co (NYSE: DF) to have earned $0.38 per share on revenue of $1.89 billion in the latest quarter. Dean Foods shares slipped 0.30 percent to $18.15 in after-hours trading.
- [By Monica Gerson]
Dean Foods Co (NYSE: DF) is expected to report its quarterly earnings at $0.38 per share on revenue of $1.89 billion.
Electronic Arts Inc. (NASDAQ: EA) is estimated to post its quarterly earnings at $0.42 per share on revenue of $888.78 million.